Back to Cancer Australia's website

Cancer Australia

Select a guideline

Recommendations for use of Sentinel node biopsy

in early (operable) breast cancer

JUNE 2008 | Incorporates published evidence to July 2007

A CLINICAL PRACTICE GUIDELINE DEVELOPED BY NATIONAL BREAST AND OVARIAN CANCER CENTRE (NBOCC)*

This document supplements guideline recommendation 9 about axillary node dissection (page 8) and information about sentinel node biopsy (page 57) contained in the National Breast Cancer Centre (NBCC)* Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001.1

National Breast and Ovarian Cancer Centre (NBOCC)* has recommendations about staging and management of the axilla in early breast cancer to supplement chapter 4.4 (pages 55-59) of the NBCC Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001.1

ISBN Print: 978-1-74127-112-6 Online: 978-1-74127-113-3 CIP: 618.190758
Cancer Australia 2011

Purpose

This guideline includes statements and recommendations based on available, high-level evidence about the use of sentinel node biopsy in women with early (operable) breast cancer. The guideline aims to provide health professionals with information to assist in making management recommendations for improved patient outcomes. NBOCC* also develops information specifically for consumers about early breast cancer diagnosis and treatment options.

Endorsed by:

* In February 2008, National Breast Cancer Centre (NBCC), incorporating the Ovarian Cancer Program, changed its name to National Breast and Ovarian Cancer Centre (NBOCC). In July 2011, NBOCC amalgamated with Cancer Australia to form a single national agency, Cancer Australia, to provide leadership in cancer control and improve outcomes for Australians affected by cancer.

Published using CeCC Docbook Manager